129 related articles for article (PubMed ID: 24891683)
1. Adult-onset unilateral disabling pansclerotic morphea.
Singh A; Singhal K; Choudhary S; Bisati S; Arora M
Indian J Dermatol; 2014 May; 59(3):316. PubMed ID: 24891683
[TBL] [Abstract][Full Text] [Related]
2. Disabling pansclerotic morphea: clinical presentation in two adults.
Maragh SH; Davis MD; Bruce AJ; Nelson AM
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
[TBL] [Abstract][Full Text] [Related]
3. Disabling pansclerotic morphea of childhood with extracutaneous manifestations.
Kura MM; Jindal SR
Indian J Dermatol; 2013 Mar; 58(2):159. PubMed ID: 23716826
[TBL] [Abstract][Full Text] [Related]
4. Unilateral linear pansclerotic morphea affecting face and limbs.
Padmavathy L; Rao LL
Indian J Dermatol Venereol Leprol; 2005; 71(3):192-4. PubMed ID: 16394411
[TBL] [Abstract][Full Text] [Related]
5. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
[TBL] [Abstract][Full Text] [Related]
6. Pansclerotic morphea: A male child with hemiatrophy of lower limb.
Dasgupta MK; Patra C; Sarkar S; Das S
Indian Dermatol Online J; 2014 Apr; 5(2):170-2. PubMed ID: 24860754
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
[TBL] [Abstract][Full Text] [Related]
8. Disabling pansclerotic morphea of children.
Diaz-Perez JL; Connolly SM; Winkelmann RK
Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
[TBL] [Abstract][Full Text] [Related]
9. Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood.
Petrov I; Gantcheva M; Miteva L; Vassileva S; Pramatarov K
Pediatr Dermatol; 2009; 26(1):59-61. PubMed ID: 19250408
[TBL] [Abstract][Full Text] [Related]
10. [Pansclerotic morphea with a rapidly fatal outcome in an 11-year-old girl].
Hardy J; Audouin-Pajot C; Abid A; Chiotasso D; Coustets B; Suc A; Timsit P; Mouthon L; Mazereeuw-Hautier J
Ann Dermatol Venereol; 2016 Dec; 143(12):836-840. PubMed ID: 27496274
[TBL] [Abstract][Full Text] [Related]
11. [Incapacitating pansclerotic morphea in childhood].
Ferrandiz C; Henkes J; González J; Peyri J
Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
Kim A; Marinkovich N; Vasquez R; Jacobe HT
J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
[TBL] [Abstract][Full Text] [Related]
13. Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution.
Melani L; Cardinali C; Giomi B; Schincaglia E; Caproni M; Fabbri P
Skinmed; 2005; 4(3):188-90. PubMed ID: 15891259
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.
Ventéjou S; Schwieger-Briel A; Nicolai R; Christen-Zaech S; Schnider C; Hofer M; Bogiatzi S; Hohl D; De Benedetti F; Morren MA
Front Immunol; 2021; 12():656407. PubMed ID: 33767715
[TBL] [Abstract][Full Text] [Related]
15. Disabling pansclerotic morphoea of childhood.
Jamalpur I; Mogili HR; Koratala A
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455178
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E
J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989
[TBL] [Abstract][Full Text] [Related]
17. Deep morphea.
Bielsa I; Ariza A
Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic, variably acid-fast bacteria in an adult patient with disabling pansclerotic morphea.
Cantwell AR; Jones JE; Kelso DW
Arch Dermatol; 1984 May; 120(5):656-61. PubMed ID: 6372700
[TBL] [Abstract][Full Text] [Related]
19. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.
Devidayal ; Singh S; Kumar L; Radotra BD
Rheumatol Int; 2002 Jan; 21(4):158-60. PubMed ID: 11843172
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Squamous Cell Carcinoma in a Patient with Disabling Pansclerotic Morphea of Childhood.
Ruiz-Matta JM; Flores-Bozo LR; Dominguez-Cherit J
Pediatr Dermatol; 2017 Jul; 34(4):e164-e167. PubMed ID: 28543434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
